Long non-coding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal

References

• Jensen RV, Hjortbak MV, Bøtker HE. Ischemic heart disease: an update. Semin Nucl Med. 2020;50(3):195–207.
   PubMed Web of Science ®Google Scholar
• Robinson JG, Huijgen R, Ray K, et al. Determining when to add nonstatin therapy: a quantitative approach. J Am Coll Cardiol. 2016;68(22):2412–2421.
   PubMed Web of Science ®Google Scholar
• Hassanin AM, Abdel-Hamid AZ. Cavernous smooth muscles: innovative potential therapies are promising for an unrevealed clinical diagnosis. Int Urol Nephrol. 2020;52(2):205–217.
   PubMed Web of Science ®Google Scholar
• Maranhão RC, Leite AC Jr. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease. Curr Pharm Des. 2015;21(9):1196–1204.
   PubMed Web of Science ®Google Scholar
• Evan G, Littlewood T. A matter of life and cell death. Science. 1998;281(5381):1317–1322.
   PubMed Web of Science ®Google Scholar
• Andrés V, Pello OM, Silvestre-Roig C. Macrophage proliferation and apoptosis in atherosclerosis. Curr Opin Lipidol. 2012;23(5):429–438.
   PubMed Web of Science ®Google Scholar
• Chong H, Wei Z, Namuhan SG, et al. The PGC-1α/NRF1/miR-378a axis protects vascular smooth muscle cells from FFA-induced proliferation, migration and inflammation in atherosclerosis. Atherosclerosis. 2020;297:136–145.
   PubMed Web of Science ®Google Scholar
• Chen LD, Zhu WT, Cheng YY, et al. T-cell death-associated gene 8 accelerates atherosclerosis by promoting vascular smooth muscle cell proliferation and migration. Atherosclerosis. 2020;297:64–73.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Zhang M, Zhang M, et al. Long non-coding RNA LOC285194 regulates vascular smooth muscle cell apoptosis in atherosclerosis. Bioengineered. 2020;11(1):53–60.
   PubMed Web of Science ®Google Scholar
• Liu Q, Huang J, Zhou N, et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013;41(9):4976–4987.
   PubMed Web of Science ®Google Scholar
• Liu W, Miao Y, Zhang L, et al. MiR-211 protects cerebral ischemia/reperfusion injury by inhibiting cell apoptosis. Bioengineered. 2020;11(1):189–200.
   PubMed Web of Science ®Google Scholar
• Sun Y, Ye P, Wu J, et al. Inhibition of intimal hyperplasia in murine aortic allografts by the oral administration of the transforming growth factor-beta receptor I kinase inhibitor SD-208. J Heart Lung Transplant. 2014;33(6):654–661.
   PubMed Web of Science ®Google Scholar
• Nuessle JM, Giehl K, Herzog R, et al. TGFβ1 suppresses vascular smooth muscle cell motility by expression of N-cadherin. Biol Chem. 2011;392(5):461–474.
   PubMed Web of Science ®Google Scholar
• Guo J, Chen H, Ho J, et al. TGF-beta-induced GRK2 expression attenuates AngII-regulated vascular smooth muscle cell proliferation and migration. Cell Signal. 2009;21(6):899–905.
   PubMed Web of Science ®Google Scholar
• Ambartsumian N, Klingelhöfer J, Grigorian M. The Multifaceted S100A4 Protein in Cancer and Inflammation. Methods Mol Biol. 2019;1929:339–365.
   PubMedGoogle Scholar
• Fei F, Qu J, Li C, et al. Role of metastasis-induced protein S100A4 in human non-tumor pathophysiologies. Cell Biosci. 2017;7(1):64.
   PubMedGoogle Scholar
• Xie R, Schlumbrecht MP, Shipley GL, et al. S100A4 mediates endometrial cancer invasion and is a target of TGF-β1 signaling. Lab Invest. 2009;89(8):937–947.
   PubMed Web of Science ®Google Scholar
• Matsuura I, Lai CY, Chiang KN. Functional interaction between Smad3 and S100A4 for TGF-beta-mediated cancer cell invasiveness. Biochem J. 2010;426(3):327–335.
   PubMedGoogle Scholar
• Kitao A, Sato Y, Sawada-Kitamura S, et al. Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. Am J Pathol. 2009;175(2):616–626.
   PubMed Web of Science ®Google Scholar
• Cunningham MF, Docherty NG, Burke JP, et al. S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn’s disease and promotes intestinal fibroblast migration. Am J Physiol Gastrointest Liver Physiol. 2010;299(2):G457–466.
   PubMed Web of Science ®Google Scholar
• Wang H, Shi J, Luo Y, et al. Long noncoding RNA loc285194 expression in human papillomavirus-positive and -negative cervical squamous cell carcinoma, C33A, and SiHa cells and transforming growth factor-β1. Clin Cancer Res. 2014;20(22):5835–5847.
   PubMed Web of Science ®Google Scholar
• Qi Y, Dai F, Gu J, et al. Biomarkers in VSMC phenotypic modulation and vascular remodeling. Die Pharmazie. 2019;74(12):711–714.
   PubMed Web of Science ®Google Scholar
• Afra S, Matin MM. Potential of mesenchymal stem cells for bioengineered blood vessels in comparison with other eligible cell sources. Cell Tissue Res. 2020;380(1):1–13.
   PubMed Web of Science ®Google Scholar
• Wang D, Uhrin P, Mocan A, et al. Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways. Biotechnol Adv. 2018;36(6):1586–1607.
   PubMed Web of Science ®Google Scholar
• Shi N, Chen SY. Smooth muscle cell differentiation: model systems, regulatory mechanisms, and vascular diseases. J Cell Physiol. 2016;231(4):777–787.
   PubMed Web of Science ®Google Scholar
• Grootaert MOJ, Moulis M, Roth L, et al. Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis. Cardiovasc Res. 2018;114(4):622–634.
   PubMed Web of Science ®Google Scholar
• Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118(4):692–702.
   PubMed Web of Science ®Google Scholar
• Zhong B, Wang Q, He J, et al. LncRNA LOC285194 modulates gastric carcinoma progression through activating Wnt/β-catenin signaling pathway. Cancer Med. 2020;9(6):2181–2189.
   PubMed Web of Science ®Google Scholar
• Wang H, Jiao H, Jiang Z, et al. Propofol inhibits migration and induces apoptosis of pancreatic cancer PANC-1 cells through miR-34a-mediated E-cadherin and LOC285194 signals. Bioengineered. 2020;11(1):510–521.
   PubMed Web of Science ®Google Scholar
• Pasic I, Shlien A, Durbin AD, et al. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res. 2010;70(1):160–171.
   PubMed Web of Science ®Google Scholar
• Yu J, Wang Z, Kinzler KW, et al. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci U S A. 2003;100(4):1931–1936.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhang L. PUMA, a potent killer with or without p53. Oncogene. 2008;27(Suppl 1):S71–83.
   PubMedGoogle Scholar
• Tinajero MG, Gotlieb AI. Recent developments in vascular adventitial pathobiology: the dynamic adventitia as a complex regulator of vascular disease. Am J Pathol. 2020;190(3):520–534.
   PubMed Web of Science ®Google Scholar
• Spiekerkoetter E, Lawrie A, Merklinger S, et al. Mts1/S100A4 stimulates human pulmonary artery smooth muscle cell migration through multiple signaling pathways. Chest. 2005;128(6):577S.
   PubMed Web of Science ®Google Scholar
• Spiekerkoetter E, Guignabert C, de Jesus Perez V, et al. S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4. Circ Res. 2009;105(7):639–647.
   PubMed Web of Science ®Google Scholar
• Li F, Shi J, Xu Z, et al. S100A4-MYH9 axis promote migration and invasion of gastric cancer cells by inducing TGF-β-mediated epithelial-mesenchymal transition. J Cancer. 2018;9(21):3839–3849.
   PubMed Web of Science ®Google Scholar
• Yu MH, Lin MC, Huang CN, et al. Acarbose inhibits the proliferation and migration of vascular smooth muscle cells via targeting Ras signaling. Vascul Pharmacol. 2018;103-105:8–15.
   PubMed Web of Science ®Google Scholar